Arabic Arabic English English French French German German

Researchers unlock immune cell contributions that could lead to new therapies for endometrial cancer

Endometrial cancer is the most common cancer of the female reproductive system. Patients who have active immune responses against cancer cells tend to have better outcomes, but much of what is known focuses on only one type of immune cell called T cells. In a new study published in Cancer Research, Moffitt Cancer Center researchers provide insight on the role of B cell immunity in endometrial cancer. Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Whole-spine MRI may be warranted in suspected child abuse

Next Post

Self-perceptions of aging and stress have significant impact on physical health, study finds

Related Posts